Literature DB >> 21253003

Abdominal fat mass is associated with adaptive immune activation: the CODAM Study.

Marielle M Thewissen1, Jan G Damoiseaux, Adriaan M Duijvestijn, Marleen M van Greevenbroek, Carla J van der Kallen, Edith J Feskens, Ellen E Blaak, Casper G Schalkwijk, Coen D Stehouwer, Jan W Cohen Tervaert, Isabel Ferreira.   

Abstract

Abdominal fat-related activation of the innate immune system and insulin resistance (IR) are implicated in the pathogenesis of cardiovascular diseases. Recent data support an important role of the adaptive immune system as well. In this study, we investigate the association between waist circumference and markers of systemic adaptive immune activation, and the potential mediating role of innate immune activation and/or IR herein. The study population consisted of 477 (304 men) individuals (mean age: 59.4 ± 7.0 years) in whom waist circumference, HOMA2-IR (IR derived from homeostasis model assessment), and markers of innate (C-reactive protein (CRP), interleukin (IL)-6, serum amyloid A (SAA)) and adaptive (neopterin, soluble CD25 (sCD25)) immune activation were measured. These markers were compiled into an adaptive and innate immune activation score by averaging the respective z-scores. After adjustments for age, sex, glucose metabolism, smoking status, prior cardiovascular disease, and other risk factors, waist circumference was associated with the adaptive (standardized regression coefficient β = 0.12 (95% confidence intervals: 0.04-0.20)) and the innate immune activation scores (β = 0.24 (0.17-0.31)), and with HOMA2-IR (β = 0.49 (0.42-0.56)). The innate immune activation score and HOMA2-IR were also positively associated with the adaptive immune activation score (β = 0.31 (0.21-0.40) and β = 0.11 (0.02-0.21), respectively). The association between waist circumference and the adaptive immune activation score was completely abolished when further adjusted for innate immune activation and HOMA2-IR (to β = -0.01 (-0.10-0.08)), and the specific mediation "effects" attributable to each of these variables were 58% and 42%, respectively. We conclude that abdominal obesity is associated with systemic adaptive immune activation and that innate immune activation and IR constitute independent and equally important pathways explaining this association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21253003     DOI: 10.1038/oby.2010.337

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  18 in total

1.  GPR105 ablation prevents inflammation and improves insulin sensitivity in mice with diet-induced obesity.

Authors:  Jianfeng Xu; Hidetaka Morinaga; Dayoung Oh; Pingping Li; Ai Chen; Saswata Talukdar; Yaël Mamane; Joseph A Mancini; Andrea R Nawrocki; Eduardo Lazarowski; Jerrold M Olefsky; Jane J Kim
Journal:  J Immunol       Date:  2012-07-09       Impact factor: 5.422

2.  Early-onset obesity and the unwanted promise of thrombosis.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2011-07       Impact factor: 2.300

3.  An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy.

Authors:  John R Koethe; Cathy A Jenkins; Bryan E Shepherd; Samuel E Stinnette; Timothy R Sterling
Journal:  Clin Infect Dis       Date:  2011-09-26       Impact factor: 9.079

Review 4.  Adipose Tissue in HIV Infection.

Authors:  John R Koethe
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

5.  Biomarkers of inflammation in HIV-infected Peruvian men and women before and during suppressive antiretroviral therapy.

Authors:  Eduardo Ticona; Marta E Bull; Jaime Soria; Kenneth Tapia; Jillian Legard; Sheila M Styrchak; Corey Williams; Caroline Mitchell; Alberto La Rosa; Alberto L A Rosa; Robert W Coombs; Lisa M Frenkel
Journal:  AIDS       Date:  2015-08-24       Impact factor: 4.177

Review 6.  Adaptive immunity in obesity and insulin resistance.

Authors:  Henrike Sell; Christiane Habich; Juergen Eckel
Journal:  Nat Rev Endocrinol       Date:  2012-07-31       Impact factor: 43.330

7.  Multiple inflammatory biomarker detection in a prospective cohort study: a cross-validation between well-established single-biomarker techniques and an electrochemiluminescense-based multi-array platform.

Authors:  Bas C T van Bussel; Isabel Ferreira; Marjo P H van de Waarenburg; Marleen M J van Greevenbroek; Carla J H van der Kallen; Ronald M A Henry; Edith J M Feskens; Coen D A Stehouwer; Casper G Schalkwijk
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

Review 8.  Adipose tissue and immune function: a review of evidence relevant to HIV infection.

Authors:  John R Koethe; Todd Hulgan; Kevin Niswender
Journal:  J Infect Dis       Date:  2013-07-21       Impact factor: 5.226

9.  A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk.

Authors:  Krasimira Aleksandrova; Shu-Chun Chuang; Heiner Boeing; Hui Zuo; Grethe S Tell; Tobias Pischon; Mazda Jenab; Bas Bueno-de-Mesquita; Stein Emil Vollset; Øivind Midttun; Per Magne Ueland; Veronika Fedirko; Mattias Johansson; Elisabete Weiderpass; Gianluca Severi; Antoine Racine; Marie-Christine Boutron-Ruault; Rudolf Kaaks; Tilman Kühn; Anne Tjønneland; Kim Overvad; J Ramón Quirós; Paula Jakszyn; María-José Sánchez; Miren Dorronsoro; Maria-Dolores Chirlaque; Eva Ardanaz; Kay-Tee Khaw; Nicholas J Wareham; Ruth C Travis; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Domenico Palli; Sabina Sieri; Rosario Tumino; Salvatore Panico; Anne M May; Richard Palmqvist; Ingrid Ljuslinder; So Yeon J Kong; Heinz Freisling; Marc J Gunter; Yunxia Lu; Amanda J Cross; Elio Riboli; Paolo Vineis
Journal:  J Natl Cancer Inst       Date:  2015-02-23       Impact factor: 13.506

10.  Iron metabolism is associated with adipocyte insulin resistance and plasma adiponectin: the Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) study.

Authors:  Nick Wlazlo; Marleen M J van Greevenbroek; Isabel Ferreira; Eugene H J M Jansen; Edith J M Feskens; Carla J H van der Kallen; Casper G Schalkwijk; Bert Bravenboer; Coen D A Stehouwer
Journal:  Diabetes Care       Date:  2012-09-06       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.